NCCN Guidelines® Updates: Discontinuing TKI Therapy in the Treatment of Chronic Myeloid Leukemia
Data from recent clinical studies indicate that discontinuation of TKI therapy (with close monitoring) may be feasible in carefully selected patients with chronic phase CML (CP-CML), prompting the introduction of a new concept known as treatment-free remission (TFR).
Category
  • Chronic Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Management of Metastatic Colorectal Cancer
The approval of new therapies has substantially expanded the treatment options for metastatic colorectal cancer (mCRC) in recent years, raising new questions about how to select the most appropriate therapy for a specific patient and how to optimally sequence these therapies.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Screening for Distress in Cancer: Implementing the Standard of Care
Distress is a risk factor for non‑adherence to treatment, such as with oral medications. Early evaluation and screening for distress leads to early and timely management of psychological distress, which in turn improves medical management.
Category
  • Distress Management
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenges with the 8th Edition of the AJCC Staging Manual - Staging of Head and Neck Cancers: Oropharyngeal Cancer
As research on clinical cancer care rapidly evolves, utilizing and implementing a staging system that is primarily based on prognostic information may have limitations.
Category
  • Head and Neck Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenges with the 8th Edition of the AJCC Staging Manual - Staging of Testicular Cancer: Germ Cell Tumors
As research on clinical cancer care rapidly evolves, utilizing and implementing a staging system that is primarily based on prognostic information may have limitations.
Category
  • Testicular Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenges with the 8th Edition of the AJCC Staging Manual - Staging of Breast Cancer
As research on clinical cancer care rapidly evolves, utilizing and implementing a staging system that is primarily based on prognostic information may have limitations.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Biosimilar Approvals for Myeloid Growth Factors and Anemia
Challenges remain in the acceptance of biosimilar medications by physicians, payers, and patients in the U.S., similar to the challenges faced by generic drugs when they were first introduced to the market.
Category
  • Anemia
  • Myeloid Growth Factors
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Harmonized Guidelines™ for Sub-Saharan Africa
Clinicians around the world use NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) as a standard for clinical decision-making.  The NCCN Harmonized Guidelines™ are targeted regional resources created as part of a collaborative effort to combat the skyrocketing cancer rate
Category
  • Breast Cancer
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Management of Muscle-Invasive Bladder Cancer
Recent implementation of the 8th edition of the AJCC Cancer Staging Manual prompted an overhaul of the treatment algorithms for muscle-invasive bladder cancer in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Bladder Cancer.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Novel Treatment Options for Neuroendocrine Tumors
There are now multiple approved treatments and several promising trials with different agents, including some directed therapies, for patients with neuroendocrine tumors (NETs). The sequencing of these treatments is controversial and will become more complicated as further drugs are approved.
Category
  • Neuroendocrine Tumors
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages